Zobrazeno 1 - 10
of 221
pro vyhledávání: '"M C, de Vernejoul"'
Autor:
Agnès Ostertag, P Clevenbergh, J-F Bergmann, M-C de Vernejoul, S Fernandez, A Lopes, M Morgand, J Evans, Pierre Sellier, Karine Champion, C Collet, S Souak, H Trout
Publikováno v:
HIV Medicine. 17:550-556
Objectives HIV-infected individuals are at increased risk of incident fractures. Evaluation of trabecular bone micro-architecture is an important tool to assess bone strength, but its use has not yet been reported in middle-aged HIV-infected male ind
Autor:
M Biosse-Duplan, M.-C. de Vernejoul
Publikováno v:
EMC - Appareil locomoteur. 5:1-6
Publikováno v:
Médecine & Longévité. 1:22-25
Resume L’augmentation de l’esperance de vie et les modifications du mode de vie sont des facteurs communs qui contribuent a l’augmentation de la prevalence de l’osteoporose et du diabete. L’epidemiologie et les mecanismes pathogeniques de l
Publikováno v:
Journal of Bone and Mineral Research. 18:1989-1994
The prevalence of osteoporosis was investigated in 88 patients with intestinal failure (IF). Osteoporosis was found in 67%, dependent of body mass index and age when IF occurred. In 56 patients on HPN, followed prospectively, changes in bone density
Publikováno v:
Clinical Nephrology. 57:261-273
Vitamin D derivatives correct high bone remodeling by decreasing plasma iPTH concentration in uremic patients with secondary hyperparathyroidism. However, without bone biopsy, plasma iPTH alone might not provide sufficient information regarding vitam
Autor:
M.-C. de Vernejoul, Frédéric Lioté, A. Leyendecker, Agnès Ostertag, F. Woimant, J.-C. Duclos-Vallée, Jean-Marc Trocello, Anne-Sophie Quemeneur, Hang-Korng Ea
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 25(11)
Wilson's disease is characterized by copper deposition, especially in the liver and central nervous system. We assessed the prevalent fractures and bone mineral density (BMD) and related risk factors in 85 patients. BMD was normal, but patients with
Publikováno v:
Hormone and Metabolic Research. 30:249-255
Human hypercalcemia of malignancy (HHM) is generally due to the release into the circulation of parathyroid hormone-related peptide (PTHrP). PTHrP stimulates osteoclastic bone resorption and renal calcium reabsorption through the activation of a rece
Autor:
M C de Vernejoul
Publikováno v:
Drugs & Aging. 12:9-14
New specific markers of bone remodelling have been developed that allow the evaluation of bone formation (plasma levels of osteocalcin and bone alkaline phosphatases) or bone resorption (collagen crosslink levels in urine). These markers can be used
Autor:
M.-C. de Vernejoul, Agnès Ostertag, Jean-Denis Laredo, Sylvie Fernandez, Christine Chappard, Françoise Peyrin
Publikováno v:
European Calcified Tissue Society Congress 2013
European Calcified Tissue Society Congress 2013, May 2013, Lisbon, Portugal. pp.PP316, ⟨10.1530/boneabs.1.PP316⟩
European Calcified Tissue Society Congress 2013, May 2013, Lisbon, Portugal. pp.PP316, ⟨10.1530/boneabs.1.PP316⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbab3644e8e819c4590b3042e4fd1bfa
https://hal.archives-ouvertes.fr/hal-00832485
https://hal.archives-ouvertes.fr/hal-00832485
Autor:
D O, Slosman, D M, Provvedini, P J, Meunier, P D, Delmas, J L, Sebert, M C, De Vernejoul, Y, Tsouderos, J Y, Reginster
Publikováno v:
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 2(1)
Accurate cross-calibration (CC) and quality control (QC) programs for dual X-ray absorptiometry (DXA) instruments are necessary in order to guarantee appropriate measurements of bone mineral density (BMD) during longitudinal studies. This article det